Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field
CA 2520541 C · Owner: Giuliani International Limited · Inventors: Monteleone, Giovanni
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to antisense oligonucleotidic sequences (ODN) against Smad7 suitably modified, and their uses in medical field as therapeutic biological agents, in particular in the treatment of chronic inflammatory bowel disease, such as Crohn~s disease and ulcerative colitis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 8, 2004 and granted May 8, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 8, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 8, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.